Progress towards a genome-derived, epitope-driven vaccine for latent TB infection.
Moise
Leonard
L
EpiVax, Inc, Providence, RI, USA.
McMurry
Julie
J
Rivera
Daniel S
DS
Carter
E Jane
EJ
Lee
Jinhee
J
Kornfeld
Hardy
H
Martin
William D
WD
De Groot
Anne S
AS
D000818:Animals; D001500:BCG Vaccine / Q000235:genetics* / Q000276:immunology; D018604:Epitope Mapping; D000939:Epitopes / Q000235:genetics* / Q000276:immunology; D006801:Humans; D014376:Tuberculosis / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control*; D032581:Tuberculosis Vaccines / Q000235:genetics* / Q000276:immunology
D001500:BCG Vaccine; D000939:Epitopes; D032581:Tuberculosis Vaccines